NFE2L2 and early-onset autosomal dominant Alzheimer disease: Overexpression of Nrf2 in astrocytes has not been investigated in Alzheimer’s disease models, and therefore it is unclear whether activation of Nrf2 specifically in astrocytes is equally effective in alleviating Alzheimer’s disease symptoms.